# The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion Injury

> **NCT05734612** · PHASE3 · UNKNOWN · sponsor: **Indonesia University** · enrollment: 80 (estimated)

## Conditions studied

- Reperfusion Injury, Myocardial

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Placebo (lactose)

## Key facts

- **NCT ID:** NCT05734612
- **Lead sponsor:** Indonesia University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-04
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2023-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05734612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05734612, "The Role of Colchicine in Reducing The Rate of Myocardial Reperfusion Injury". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05734612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*